|
³ëº¸³ëµð½ºÅ©Á¦¾à(ÁÖ) |
[±Û·Î¹ú Á¦¾à»ç] Multi-Channel Engagement Manager
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
7³â¡è |
ä¿ë½Ã |
04.28 |
|
|
³ëº¸³ëµð½ºÅ©Á¦¾à(ÁÖ) |
[±Û·Î¹ú Á¦¾à»ç] Market Access Lead, Cardiovascular and E
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
3³â¡è |
ä¿ë½Ã |
04.28 |
|
|
³ëº¸³ëµð½ºÅ©Á¦¾à(ÁÖ) |
[±Û·Î¹ú Á¦¾à»ç] Medical Advisor ä¿ë
¼¿ï ¼ÛÆı¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
04.28 |
|
|
³ëº¸³ëµð½ºÅ©Á¦¾à(ÁÖ) |
[±Û·Î¹ú Á¦¾à»ç] (Sr.) Regional Medical Advisor / (Sr.) M
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
4³â¡è |
ä¿ë½Ã |
04.28 |
|
|
¾ÆÁÖ¾àÇ°(ÁÖ) |
¾ÆÁÖ¾àÇ°¢ß °Ç°±â´É½ÄÇ° MD(¿Â¶óÀοµ¾÷) °æ·Â»ç¿ø ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°Ç°º¸Á¶½ÄÇ°/ÈÀåÇ°¿µ¾÷ |
2³â¡è |
05.06 |
04.24 |
|
|
(ÁÖ)Çѵ¶ |
MSL / MI / BD(»ç¾÷°³¹ß) / ÀλçÃѹ« / ´ç´¢¸¶ÄÉÆà / Àü½Ã±â
¼¿ï °³²±¸ | Çз¹«°ü |
Çмú/±³À°/»ó´ã |
°æ·Â¹«°ü |
05.06 |
04.24 |
|
|
¾Ëº¸Á¨ ÄÚ¸®¾Æ ÁÖ½Äȸ»ç |
Senior RA Specialist (°æ·Â 5³â ÀÌ»ó)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
5³â¡è |
04.30 |
04.08 |
|
|
¾Ëº¸Á¨ ÄÚ¸®¾Æ ÁÖ½Äȸ»ç |
RA Specialist (°æ·Â 1³â ÀÌ»ó)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
04.30 |
04.08 |
|
|
´º·ÎÇÍ ÁÖ½Äȸ»ç |
ÇØ¿Ü¿µ¾÷
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
3³â¡è |
ä¿ë½Ã |
04.26 |
|
|
Novotech |
Pharmacovigilance Associate (Snr)_Korean Speaker Only
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
1³â¡è |
ä¿ë½Ã |
03.13 |
|
|
Novotech |
[Novotech] Associate Clinical Data Manager Á¤±ÔÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
STAT/DM |
1³â¡è |
ä¿ë½Ã |
04.03 |
|
|
Novotech |
Associate Clinical Data Manager
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
STAT/DM |
1³â¡è |
ä¿ë½Ã |
04.22 |
|
|
Novotech |
[Novotech] Business Development Manager ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
04.04 |
|
|
Janssen |
[Janssen] Project Manager (Local Trial Manager)
¼¿ï ¿ë»ê±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
2³â¡è |
ä¿ë½Ã |
01.29 |
|
|
¹Ì·¡ÄÄÆÛ´Ï |
[¹Ì·¡ÄÄÆÛ´Ï/¼¿ï] ÇコÄɾî(ÀÇ·á±â±â) - ÇØ¿Ü¿µ¾÷
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
02.21 |
|